643 related articles for article (PubMed ID: 34156871)
21. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
[No Abstract] [Full Text] [Related]
22. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
23. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to recombinant SARS-CoV-2 spike protein entry in the lungs of high-fat diet-induced obese mice.
Gotoh K; Satoh F; Uesugi H; Noguchi T; Matsuda N; Sada K; Miyamoto S; Ozeki Y; Yoshida Y; Okamoto M; Masaki T; Kawabe T; Shibata H
FASEB J; 2024 May; 38(10):e23656. PubMed ID: 38752523
[TBL] [Abstract][Full Text] [Related]
25. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
26. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
27. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
[TBL] [Abstract][Full Text] [Related]
28. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
[TBL] [Abstract][Full Text] [Related]
30. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
31. Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein.
Romero MJ; Yue Q; Singla B; Hamacher J; Sridhar S; Moseley AS; Song C; Mraheil MA; Fischer B; Zeitlinger M; Chakraborty T; Fulton D; Gan L; Annex BH; Csanyi G; Eaton DC; Lucas R
Front Immunol; 2023; 14():1241448. PubMed ID: 37638055
[TBL] [Abstract][Full Text] [Related]
32. The Effects of Aβ
Hsu JT; Tien CF; Yu GY; Shen S; Lee YH; Hsu PC; Wang Y; Chao PK; Tsay HJ; Shie FS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360989
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
34. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein.
Nuovo GJ; Magro C; Shaffer T; Awad H; Suster D; Mikhail S; He B; Michaille JJ; Liechty B; Tili E
Ann Diagn Pathol; 2021 Apr; 51():151682. PubMed ID: 33360731
[TBL] [Abstract][Full Text] [Related]
35. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.
Amruta N; Engler-Chiurazzi EB; Murray-Brown IC; Gressett TE; Biose IJ; Chastain WH; Befeler JB; Bix G
Life Sci; 2021 Nov; 284():119881. PubMed ID: 34389403
[TBL] [Abstract][Full Text] [Related]
36. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
37. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.
Wang BQ; Shi M; Zhang JP; Wu X; Chang MJ; Chen ZH; Shen HH; Song YL; Zhou J; Bai CX
Shock; 2019 Feb; 51(2):235-246. PubMed ID: 29438223
[TBL] [Abstract][Full Text] [Related]
39. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
[TBL] [Abstract][Full Text] [Related]
40. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
